Terminated NCT05741502
This summary needs review. Please check the official study record and contact the research team for details.
In Columbus Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries United States
Sponsor Ohio State University
Condition Schizophrenia Completed NCT00996242
This summary needs review. Please check the official study record and contact the research team for details.
In Gothenburg Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 23 Years to 56 Years
Countries Sweden
Sponsor Göteborg University
Condition Schizophrenia Completed NCT00257023
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 20 Years to 64 Years
Countries
Sponsor Janssen Pharmaceutical K.K.
Condition Schizophrenia Completed NCT01895452
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 70 Years
Countries United States, Bulgaria, Malaysia, ...
Sponsor Alkermes, Inc.
Condition Schizophrenia Completed NCT01175135
This study is completed in the United States, in Germany, and in Ukraine. It is testing Efficacy, Safety, And Tolerability Of PF-02545920 for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, Germany, Ukraine
Sponsor Pfizer
Condition Schizophrenia Completed NCT01634542
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Buenos Aires Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Observational i A study where researchers collect information without assigning a treatment. Over 18 Years
Countries France, Canada, United Kingdom, ...
Sponsor Hoffmann-La Roche
Condition Schizophrenia Terminated NCT01894984
This study was terminated. It is testing Risperidone Long-Acting Injection for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries
Sponsor Xian-Janssen Pharmaceutical Ltd.
Condition Schizophrenia Completed NCT00473434
This study is completed. It focuses on schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries
Sponsor Janssen-Cilag Pty Ltd
Condition Schizophrenia Completed NCT01646827
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Cerritos Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 64 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT01716858
This summary needs review. Please check the official study record and contact the research team for details.
In Chiba Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other From 20 Years to 65 Years
Countries Japan
Sponsor Chiba University
Condition Schizophrenia Completed NCT00823199
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries
Sponsor Bronx Psychiatric Center
Condition Schizophrenia Completed NCT01355952
This study is completed in the United States. It is testing Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss for schizophrenia.
In New Haven Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other From 18 Years to 70 Years
Countries United States
Sponsor Yale University
Condition Schizophrenia